2016-03-15T00:00:00.000-04:00
personal trading style,0.598412
hepatic infectious disease,-0.762958
average rating,-0.360175
Russell Frank,0.43576
price target,-0.0120187
legal filing,-0.245224
Alnylam Pharmaceuticals Inc.,0.560435
shares,0.370602
concise daily summary,0.448938
average target price,-0.373157
Alnylam Pharmaceuticals,0.0389555
stock,-0.019447
stock broker,0.245696
hepatic infectious diseases,-0.777447
InvestorPlace Broker Center,0.555736
RNAi therapeutics,-0.56796
1-year high,-0.582672
rating,-0.0333751
biopharmaceutical company,0.415221
research report,-0.0120187
year-over-year basis,-0.239056
quarter,0.205918
